The Promise of Personalized Medicine | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Advertisements

Feeds:: Posts; Comments

« Personalized Medicine in NSCLC

Gene Sequencing – to the Bedside »

The Promise of Personalized Medicine

March 3, 2013 by larryhbern

The Promise of Personalized Medicine

Reporter: Larry H Bernstein, MD, FCAP

Realizing the Promise of Personalized Medicine

Harvard Business Review

MG Aspinal, RG Hamermesh

Obsolete business models, regulations, reimbursement systems, and physicians stand in the way

http://missionfacilitators.com/Articles/Organizational-development/Articles/realizing-the-promise-of-personalized-medicine.pdf/

NewYear for Angels

NewYear for Angels (Photo credit: Wikipedia)

BusinessModel

BusinessModel (Photo credit: Wikipedia)

Harvard Business Review and Fifth Global Peter Drucker Forum Form Partnership (prweb.com)
Is Your Company Ready for the Circular Economy? – Eric Hellweg – Harvard Business Review (entrepreneurshipmatters.com)
Kaggle Visualization Contest yields insights on influence at Harvard Business Review, by @stephanieoverby (nextlevelofnews.com)
Attitudes of Patients about Personalized Medicine (pharmaceuticalintelligence.com)
ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer

Advertisements

Posted in FDA Regulatory Affairs, Genome Biology, Genomic Testing: Methodology for Diagnosis, Health Economics and Outcomes Research, Health Law & Patient Safety, Molecular Genetics & Pharmaceutical, Nanotechnology for Drug Delivery, Personalized and Precision Medicine & Genomic Research, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Investment, Population Health Management, Genetics & Pharmaceutical, Regulated Clinical Trials: Design, Methods, Components and IRB related issues, Technology Transfer: Biotech and Pharmaceutical | Tagged Business, Business model, Education, Harvard Business Review, Harvard Business School, Harvard University, Larry H. Bernstein, Massachusetts, United States | 1 Comment

One Response

on March 27, 2013 at 7:00 PM | Reply Genomic Liberty of Ownership, Genome Medicine and Patenting the Human Genome | Pharmaceutical Intelligence

[…] 20.6 The Promise of Personalized Medicine […]

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Google account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s

%d bloggers like this: